BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11459650)

  • 1. Synthesis and biological evaluation of didemnin photoaffinity analogues.
    Vera MD; Pfizenmayer AJ; Ding X; Ahuja D; Toogood PL; Joullié MM
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1871-4. PubMed ID: 11459650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
    Vidya R; Eggen M; Georg GI; Himes RH
    Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lys3]Didemnins as potential affinity ligands.
    Vera MD; Pfizenmayer AJ; Ding X; Xiao D; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(1):13-6. PubMed ID: 11140723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products as probes of cell biology: 20 years of didemnin research.
    Vera MD; Joullié MM
    Med Res Rev; 2002 Mar; 22(2):102-45. PubMed ID: 11857636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; Joullié MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
    Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
    Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytostatic activities of didemnin derivatives.
    Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
    J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of [(2S)-Hiv2]didemnin M.
    Liang B; Vera MD; Joullié MM
    J Org Chem; 2000 Jul; 65(15):4762-5. PubMed ID: 10959892
    [No Abstract]   [Full Text] [Related]  

  • 10. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha.
    Crews CM; Collins JL; Lane WS; Snapper ML; Schreiber SL
    J Biol Chem; 1994 Jun; 269(22):15411-4. PubMed ID: 8195179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the binding of didemnins to human elongation factor eEF1A and rationale for the potent antitumor activity of these marine natural products.
    Marco E; Martín-Santamaría S; Cuevas C; Gago F
    J Med Chem; 2004 Aug; 47(18):4439-52. PubMed ID: 15317456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis of a conformationally constrained didemnin B analog.
    Xiao D; Vera MD; Liang B; Joullié MM
    J Org Chem; 2001 Apr; 66(8):2734-42. PubMed ID: 11304195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein synthesis by didemnins: cell potency and SAR.
    Ahuja D; Geiger A; Ramanjulu JM; Vera MD; SirDeshpande B; Pfizenmayer A; Abazeed M; Krosky DJ; Beidler D; Joullié MM; Toogood PL
    J Med Chem; 2000 Nov; 43(22):4212-8. PubMed ID: 11063617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Didemnins and tunichlorin: novel natural products from the marine tunicate Trididemnum solidum.
    Rinehart KL; Kishore V; Bible KC; Sakai R; Sullins DW; Li KM
    J Nat Prod; 1988; 51(1):1-21. PubMed ID: 3373220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.
    Geldof AA; Mastbergen SC; Henrar RE; Faircloth GT
    Cancer Chemother Pharmacol; 1999; 44(4):312-8. PubMed ID: 10447579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
    Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
    Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
    J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.